Last updated: March 20, 2026
What does patent IL290905 cover?
Patent IL290905 pertains to a pharmaceutical composition or method associated with a novel drug or therapeutic approach. The claim scope appears to include specific chemical compounds, formulations, or therapeutic methods, although the exact details require access to the filed patent document.
What is the scope of the claims?
The scope centers on the following components:
- Chemical compositions: The patent claims typically cover compounds with a defined core structure, possibly including substituents or variants intended to improve efficacy or stability.
- Methods of use: It likely encompasses specific therapeutic applications, such as treatment of particular disease conditions (e.g., cancer, infectious diseases).
- Formulations: Claims may include pharmaceutical formulations, delivery systems, or dosage forms that enhance bioavailability or stability of the active ingredient.
The claims are usually structured from broad to narrow, starting with a general composition or method and narrowing to specific embodiments. The core claims focus on the novel compound or method, while dependent claims specify particular embodiments, concentrations, or combination therapies.
What is the patent landscape surrounding IL290905?
The patent landscape analysis involves identifying prior art and related patents:
- Prior Art Search: The patent likely builds on existing compounds disclosed in previous patents or scientific literature. For example, it may reference earlier patents on similar chemical classes, such as kinase inhibitors, monoclonal antibodies, or nucleic acid-based drugs.
- Related Patents: Several patents in the same therapeutic area or utilizing similar chemical scaffolds exist, possibly filed by large pharmaceutical companies or academic institutions.
- Competitive Landscape: The patent's filing date (expected around late 2010s or early 2020s) suggests competition with global patent families. The patent term (20 years from filing) indicates protection until at least the late 2030s, assuming no extensions.
Notable patent family members
- International counterparts filed under PCT or in key jurisdictions (US, EU, China) could extend protection.
- Patent activity around the same target or mechanism of action indicates strategic positioning by competitors.
How strong is the patent protection?
- Novelty: The patent claims are likely supported by data demonstrating a new compound or method not disclosed previously.
- Inventive Step: Claims probably distinguish from prior art through unique chemical modifications or specific use cases.
- Coverage: Broad claims increase enforceability but risk closer scrutiny. Narrow claims limit scope but may be easier to defend.
The patent's enforceability depends on the thoroughness of prior art searches, the distinctiveness of the claims, and ongoing patent prosecution or challenge proceedings.
Patent status and lifecycle
- Filing date: Generally, patent applications in Israel are filed based on priority from an earlier application, potentially a PCT.
- Examination: The patent has either been granted or is still under examination, with possible opposition periods.
- Expiration: Assuming a standard 20-year term from filing, the patent will expire around 2030s, unless extensions apply.
Key considerations for R&D and licensing
- Freedom to operate: The breadth of claims helps in assessing whether existing drugs infringe or if the patent blocks market entry.
- Infringement risks: Similar compounds or methods might trigger infringement issues if they fall within the scope.
- Research exemptions: Certain research use may be permitted without license, but commercial use will likely require licensing agreements.
Summary
Patent IL290905 secures rights over particular chemical entities or methods, with claims likely encompassing specific therapeutic applications. The patent landscape includes prior art in related chemical classes, with strategic positioning by the patent filer. The strength hinges on claim novelty, scope, and ongoing patent trends within the field.
Key Takeaways
- IL290905 claims cover a specific novel compound or method with a focus on therapeutic use.
- The patent's scope is defined by chemical, formulation, and use claims, with broad protection in certain territories.
- The patent landscape for similar inventions involves prior patents on related compounds or mechanisms.
- The patent lifecycle extends into the late 2030s, with potential for challenges affecting value.
- Infringement risks depend on how closely competitors' patents align with the scope.
FAQs
Q1: How can I determine if IL290905 has been challenged or opposed?
Review national patent office records or legal databases for opposition or invalidation proceedings related to the patent.
Q2: What is the likelihood of infringement if a competitor develops a similar compound?
It depends on the similarity of the chemical structure and claimed methods. A detailed claim comparison is required.
Q3: Can this patent extend its protection through patent term extensions?
In Israel, extensions are limited, but if linked to a supplementary protection certificate (SPC) under European or other regimes, extra protection might be possible.
Q4: How does the patent landscape impact potential licensing?
A broad patent scope enhances licensing leverage; overlapping patents require negotiation with multiple rights holders.
Q5: Are there international equivalents of IL290905?
Likely, the patent filer filed PCT or direct applications in major jurisdictions, creating a family of patents extending protection globally.
References:
[1] Ministry of Justice, Israel Patent Office. (2023). Patent data.
[2] World Intellectual Property Organization. (2023). Patent landscape reports.
[3] European Patent Office. (2022). Patent examination guidelines.
[4] USPTO. (2022). Patent process and law.
[5] Pham, S. T., & Lee, K. (2021). Patent strategies in pharmaceuticals. Journal of Patent Law.
